OVERVIEW

Anticoagulation Reversal: Case 2 - Converting Between Anticoagulants is organized by Foundation for Care Management (FCM) .

Effective Date: August 15, 2017
Expiration Date: August 14, 2019
Format: Self Instructional - Audio Visual Voice-Over with Slides
Maximum Credits: .5 AMA PRA Category 1 CME Credit™(approved for American Board of Internal Medicine Maintenance of Certification (ABIM-MOC), .5 Nursing Contact Hours (.5 Pharmacotherapeutic Hours), .5 Pharmacy CE (Knowledge Based)
Estimated Completion Time: 0.5 hour

Target Audience & Cost:
This program is intended for primary care physicians, physician assistants, nurse practitioners, nurses, and other health care professionals interested in the treatment and management of patients at risk for stroke and working as a team for better patient outcomes.

There is no cost to participate in this program.

Program Summary:
This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care; compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs) and be able to convert from one anticoagulant to another.

Outcome Objective:
Upon completion of this CME/CE activity the healthcare provider will be able to:

• Explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care.
• Compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs).
• Describe a strategy for conversion from one anticoagulant to another

Additional details will be posted as soon as they are available.